The American journal of cardiology
The American journal of cardiology
Audio Summaries
Every issue of The American journal of cardiology moves the field forward, but reading every paper cover-to-cover isn't realistic. OSLR turns each article into a 3-minute audio summary so you can stay current while you commute, round, or work out.
Recent summaries
The latest articles summarized from The American journal of cardiology.
Longitudinal NT-proBNP Target Attainment and Clinical Outcomes in Heart Failure With Reduced Ejection Fraction: A Landmark Analysis of the GUIDE-IT Trial.
Nov 19, 2026
This secondary landmark analysis of the GUIDE-IT trial asked whether achieving longer-term NT-proBNP target attainment (≤1000 pg/mL across pre-landmark visits) predicts lower risk of all-cause hospitalization or death in HFrEF patients who were event-free at 180 days. Among 324 participants, greater attainment was associated with lower risk (each 10% increase HR 0.89; ≥50% vs <50% attainment HR 0.44), but this prognostic benefit was no longer significant after adjusting for the most recent NT-proBNP value (HR 0.97, P=0.51). The authors conclude that longitudinal target attainment carries prognostic information that largely overlaps with the single most recent NT-proBNP measurement, rather than adding independent value.
Eximer Laser Coronary Atherectomy in the Current era of Complex Percutenoues Coronary Intervention: New Insights from the ACCELERATE (eAst siCily exCimEr LasER ATherEctomy) Registry.
Nov 19, 2026
This study compared procedural, in-hospital, and long-term outcomes of excimer laser coronary atherectomy (ELCA) in patients treated for calcified de novo lesions (CDNL) versus in-stent restenosis (ISR) within the multicenter ACCELERATE Registry of 320 consecutive patients. Procedural success was high overall (97%, with 99% for CDNL vs. 95.1% for ISR), and the authors concluded that ELCA is safe and effective for complex lesions and may provide superior long-term outcomes for CDNL, particularly with lower target lesion revascularization (TLR) rates at follow-up.
Timing of Coronary Angiography After Successful Fibrinolysis and Clinical Outcomes in ST-Segment Elevation Myocardial Infarction Patients.
Nov 19, 2026
This nationwide retrospective cohort of 130,322 STEMI patients treated with successful fibrinolysis asked whether the timing of coronary angiography (2-6 hours vs. 6-24 hours after fibrinolysis) affects outcomes. Angiography at 2-6 hours was associated with less new-onset heart failure and lower long-term all-cause and cardiac mortality, with no significant increase in in-hospital bleeding or mortality, although these were observational findings and the 2-6-hour group had more initial TIMI flow grade <3. The results support prospective trials to further evaluate optimal angiography timing within the guideline-recommended 2-24-hour window.
Cardiovascular Outcomes of Semaglutide in Adults With Congenital Heart Disease.
Nov 19, 2026
This retrospective TriNetX cohort study asked whether semaglutide, compared with DPP-4 inhibitors, is associated with better outcomes in adults with congenital heart disease and type 2 diabetes, a population excluded from cardiovascular outcome trials. In 1,422 propensity-matched pairs followed for 3 years, semaglutide was associated with lower all-cause mortality (HR 0.66), hospitalization (HR 0.68), and ED visits (HR 0.85), along with lower MACE, heart failure, and stroke, though a prespecified negative control was elevated, suggesting residual confounding from differences in healthcare engagement. The authors conclude the findings are hypothesis-generating only, given the observational design and imbalances such as more aortic valve disease among semaglutide users.
Differential Reverse Remodeling but Preserved Clinical Benefit of Sacubitril/Valsartan in Ischemic vs Non‑Ischemic HFrEF.
Nov 18, 2026
This multicenter retrospective study asked whether left ventricular reverse remodeling (LVRR) after sacubitril/valsartan differs between ischemic and non-ischemic heart failure with reduced ejection fraction, and whether LVRR relates to clinical outcomes. Among 608 patients, both groups improved significantly, but ischemic patients showed smaller LVEF gains and smaller reductions in end-systolic volume index. LVRR was associated with fewer all-cause deaths or HF rehospitalizations regardless of etiology, although it explained only a modest share (about 9%) of the pre-to-post treatment association with outcome.
Immune checkpoint inhibitors-induced -induced vs. Conventional Myocarditis: Navigating Pathophysiological and Clinical Divergences.
Nov 18, 2026
This review compares immune checkpoint inhibitor-induced myocarditis (ICI-M) with conventional myocarditis (CM) to determine how their pathophysiology, clinical presentation, diagnosis, and management differ. The authors find that ICI-M is a hyper-acute, T-cell-mediated toxicity that arises early (within 30-60 days) and carries higher mortality and conduction/arrhythmic risk, often with non-specific symptoms, preserved ejection fraction, and overlap with myositis. They conclude that advanced imaging (GLS, CMR parametric mapping), immediate ICI discontinuation with high-dose immunosuppression, and dedicated cardio-oncology pathways are needed for early recognition and improved outcomes.
Artificial Intelligence and Cardiovascular Disease Prevention: Newton's Second Law Readdressed with a Cautionary Note.
Nov 18, 2026
This review uses Newton's second law (Force = Mass × Acceleration) as a metaphor to ask how artificial intelligence can strengthen cardiovascular prevention beyond static, conventional risk estimation. The authors argue that AI can integrate multimodal and longitudinal data to improve risk prediction, uncover latent phenotypes, detect subclinical disease earlier, and enable continuous, personalized intervention. They conclude that AI's value will ultimately depend on moving from prediction to demonstrable reductions in cardiovascular events and mortality, delivered sustainably and equitably.
Effect of High-Intensity Statin Therapy on Coronary Plaque Composition Assessed by Machine Learning-Based Optical Coherence Tomography Analysis.
Nov 18, 2026
This post hoc substudy of IBIS-4 used AI-assisted optical coherence tomography to ask whether high-intensity rosuvastatin therapy produces measurable longitudinal changes in coronary plaque composition in nonculprit vessels of STEMI patients. In 45 vessels from 33 patients, the analysis showed thicker fibrous caps, reduced lipid volume and relative lipid content, and a higher relative fibrous and calcific proportion, a pattern consistent with plaque stabilization. The authors conclude that AI-assisted serial OCT analysis can capture this stabilization signature, supporting its use in future longitudinal imaging studies.
Rotablator Burr Entrapment: A Systematic Review of 215 Published Cases, Mechanisms, and Management.
Nov 17, 2026
This systematic review pooled 215 published cases of Rotablator burr entrapment to classify its mechanisms and evaluate how it has been managed over time. The authors found an overall incidence of about 0.6% of rotational atherectomy procedures, with intralesional wedging, the Kokeshi phenomenon, and stent-related entrapment as the most common mechanisms. Percutaneous retrieval succeeded in most recent cases (surgical bailout fell from 66.7% before 2010 to 5.5% in 2020-2026), supporting a mechanism-based, stepwise approach to burr retrieval.
Beyond the Guidelines: Successful CRT-D Rescue in Patients Unable to Tolerate Guideline-Directed Medical Therapy.
Nov 16, 2026
This case report describes two patients with advanced non-ischemic cardiomyopathy, LBBB, QRS 166-168 ms, and LVEF <20%, who were inotrope-dependent and could not tolerate GDMT, and thus did not meet guideline prerequisites for CRT-D. The authors asked whether CRT-D could serve as a salvage or enabling therapy in this population, and both patients were weaned off intravenous inotropes, improved from NYHA Class IV to Class II at one year, had no HF hospitalizations, and showed LVEF gains. Given the very limited sample size of two, the authors conclude that prospective studies are needed to define appropriate selection criteria.
